Results 181 to 190 of about 3,756,856 (305)
Aims This study looks at the status of the same drugs conditionally approved by the Food and Drug Administration and Health Canada for the same oncology indication. Methods Lists of oncology drugs with a conditional approval from the Food and Drug Administration and Health Canada were generated and drug pairs with the same indication were matched ...
Joel Lexchin
wiley +1 more source
The Reverse Risk Register Approach to Understanding Systemic Factors in Risk Analysis and Management Case Studies. [PDF]
Thekdi S, Aven T.
europepmc +1 more source
Operationalizing fair AI in healthcare: a scoping review of bias mitigation, monitoring, auditing, and governance strategies. [PDF]
Rebocho AT +3 more
europepmc +1 more source
Within the ConcePTION project we set out to design two mother–infant pair studies collecting breast milk and plasma from the mother and plasma from the infant (for metformin and prednisolone) in order to demonstrate the premises and conditions for investigating potential drug transfer in association with breastfeeding.
Mats Hansson +11 more
wiley +1 more source
Legal compliance through design
In this paper we present the preliminary results of a literature survey conducted in the context of a larger research project on legal compliance by design (LCbD) and legal compliance through design (LCtD). Even though a rich set of approaches and frameworks are available, our analysis shows that there is less focus on legal compliance in general, and ...
Hashmi, Mustafa +2 more
openaire +1 more source
DMP's ethical and legal compliance
This training resource has been developed in a project funded by the Finnish Ministry of Education and Culture and coordinated by the Tampere University, Data Management Training Development Project.
openaire +1 more source
Abstract Despite regulatory progress being made in the past two decades, off‐label drug use in paediatrics remains pervasive, with prevalence estimated between 3% and 97% of prescriptions across different clinical settings. Off‐label use—defined as prescribing outside the conditions described in the Summary of Product Characteristics (SmPC)—is often ...
Tjitske M. van der Zanden +3 more
wiley +1 more source
Mitigating climate-related health risks in Lebanon: implementation of national standards for climate-ready hospitals. [PDF]
Matta E +16 more
europepmc +1 more source
Abstract Aim The aim of this study was to assess the general and product‐specific experiences of MAHs use of RWD/RWE in medicines development and in their regulatory submissions, and to explore organizational aspects of MAHs related to RWD/RWE. Methods An electronic survey was conducted, and information collected directly from MAHs.
Sini M. Eskola +5 more
wiley +1 more source
Regulators use expedited approval pathways to speed market approval and patient access to promising new drugs. However, there is uncertainty about whether these pathways are successful in approving drugs with significant therapeutic advantages. This systematic review aims to examine the safety, effectiveness and cost‐effectiveness of drugs approved via
Ashleigh Hooimeyer +4 more
wiley +1 more source

